19^th World Congress on Infection Prevention and Control August 21-22, 2023 Barcelona, Spain

Track 1: Infection Prevention and Control

Infection prevention and control (IPC) is a practical, evidence-based approach preventing patients and health workers from being harmed by avoidable infections. Effective IPC requires constant action at all levels of the health system, including policymakers, facility managers, health workers and those who access health services. IPC is unique in the field of patient safety and quality of care, as it is universally relevant to every health worker and patient, at every health care interaction. Defective IPC causes harm and can kill. Without effective IPC it is impossible to achieve quality health care delivery. Infection prevention and control effects all aspects of health care, including hand hygiene, surgical site infections, injection safety, antimicrobial resistance and how hospitals operate during and outside of emergencies.

Track 2: Covid_19 Infections

Coronavirus disease (COVID-19) is an infectious disease caused by the SARS-CoV-2 virus. Most people infected with the virus will experience mild to moderate respiratory illness and recover without requiring special treatment. However, some will become seriously ill and require medical attention. Older people and those with underlying medical conditions like cardiovascular disease, diabetes, chronic respiratory disease, or cancer are more likely to develop serious illness. Anyone can get sick with COVID-19c and become seriously ill or die at any age. The best way to prevent and slow down transmission is to be well informed about the disease and how the virus spreads. Protect yourself and others from infection by staying at least 1 metre apart from others, wearing a properly fitted mask, and washing your hands or using an alcohol-based rub frequently.

Track 3: Causes and Symptoms of Infections

Infectious diseases are disorders caused by organisms such as bacteria, viruses, fungi or parasites. Many organisms live in and on our bodies. They're normally harmless or even helpful. But under certain conditions, some organisms may cause disease. Some infectious diseases can be passed from person to person. Some are transmitted by insects or other animals. And you may get others by consuming contaminated food or water or being exposed to organisms in the environment. Signs and symptoms vary depending on the organism causing the infection, but often include fever and fatigue. Mild infections may respond to rest and home remedies, while some life-threatening infections may need hospitalization.

Track 4: SARS Coronavirus

COVID-19 is caused by a virus called SARS-CoV-2. It is part of the coronavirus family, which include common viruses that cause a variety of diseases from head or chest colds to more severe (but more rare) diseases like severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS). Like many other respiratory viruses, coronaviruses spread quickly through droplets that you project out of your mouth or nose when you breathe, cough, sneeze, or speak. The spike protein is the part of the virus that attaches to a human cell to infect it, allowing it to replicate inside of the cell and spread to other cells.

Track 5: Infection Control Procedures

Standard precautions are meant to reduce the risk of transmission of bloodborne and other pathogens from both recognized and unrecognized sources. They are the basic level of infection control precautions which are to be used, as a minimum, in the care of all patients. In addition to hand hygiene, the use of personal protective equipment should be guided by risk assessment and the extent of contact anticipated with blood and body fluids, or pathogens.

Track 6: Global Trends in Emerging Infections

Infectious diseases are now emerging or reemerging almost every year. This trend will continue because a number of factors, including the increased global population, aging, travel, urbanization, and climate change, favor the emergence, evolution, and spread of new pathogens.

Track 7: Global Market on Infections

The global infectious disease diagnostic market was valued at $23,321.99 million in 2020, and is estimated to reach $39,941.37 million by 2030, growing at a CAGR of 6.8% from 2021 to 2030. Infectious disease diagnosis is defined as a laboratory test, which is executed with the help of skilled technicians and physicians to diagnose infectious diseases. It is a diagnostic procedure in which the causative organism of an infectious disease is characterized and identified. The sample of urine, blood, mucus, or other body fluids are analyzed to provide information about the causative organism by the use of various diagnosis procedure and instruments. 

Track 8: Infection Control in Critical Care

The intensive care unit (ICU) of the hospital has always been where the most vulnerable patients are kept, so they can be closely monitored and treated, often with a one-to-one ratio of nurse to patient, for the most scrupulous of care. Even with great advances in medical technology, these patients continue to be at the greatest risk for infections that are often avoidable by taking a few simple precautions. Healthcare workers treating these patients literally hold life and death in their hands.

Track 9: Emerging and Re-Emerging Infections

Emerging and Re-Emerging Infectious Diseases (EIDs) are infections that have newly appeared in a population or have existed previously but are rapidly increasing in incidence or geographic range. Examples include HIV/AIDS, variant Creutzfeld-Jacobs disease (vCJD) and SARS as well as reemerging diseases such as chikungunya, and influenza. Research on emerging infectious diseases has been included in the Commission framework programmes for research since their inception. 

Track 10: Epidemiology of Emerging and Re-Emerging Infections

The spectrum of human pathogens and the infectious diseases they cause is continuously changing through evolution, selection and changes in the way human populations interact with their environment and each other. New human pathogens often emerge or re-emerge from an animal reservoir, emphasizing the central role that non-human reservoirs play in human infectious diseases. The 1918 pandemic of influenza virus A/H1N1 and the 2020 pandemic of coronavirus disease 2019 (COVID-19) are the most dramatic examples of this in recent human history.

Track 11: Immunizations

Immunization is the process of giving a vaccine to a person to protect them against disease. Immunity (protection) by immunization is similar to the immunity a person would get from disease, but instead of getting the disease you get a vaccine. This is what makes vaccines such powerful medicine. Most vaccines are given by needle (injection) but some are given by mouth (orally) or sprayed into the nose (nasally). Immunizations are also called vaccinations, needles, shots or jabs.

Relevant Conferences:  

Infection Prevention Conferences 2023 | Infection Prevention Berlin Conferences | Infection Control Germany Events | Infection Prevention 2023 Europe  | Scientific Programs on Infection Prevention  | Best Infection Prevention 2023 Conferences |  Infection Control physical conferences |  Infection Prevention  Conferences

Infectious Diseases Conferences 2023 Europe | Viral Disease Conferences | Epidemiology Conferences | Infection Control Conferences | Parasitic Diseases Conferences | Fungal Diseases Conferences | Infection Conferences | Infection Prevention Conferences | Infection Control Conferences | Bacterial Conferences | Viral Diseases Conferences | Infectious Diseases Conferences | Infectious Diseases Conferences 2023 | Infectious Diseases Conferences USA | Infectious Diseases Conferences 2023 Asia.

10^th International Congress on Infectious Diseases January 23-24, 2023 Barcelona, Spain; 12^th International Conference on Tropical medicine & infectious diseases January 23-24, 2023 Barcelona, Spain; 8^th World Congress on Public Health  and Nutrition April 10-11, 2023 Vienna, Austria; 37th International Conference on Immunology & Immunogenetics May 24-25, 2023 Vienna, Austria

 4^th International Conference On Breast Pathology and Cancer Diagnosis August 15-16, 2023, Amsterdam, Netherlands ; 12th International Conference on Applied Microbiology, Clinical Microbiology and Infectious Diseases August 08-09, 2023 Zurich, Switzerland ; 17th International Conference on European Immunology April 17-18, 2023 Rome, Italy; 16th Global Summit on Immunology and Cell Biology April 17-18, 2023 Rome, Italy

Europe:

Infection Prevention Society, Healthcare Infection Society, British Society of Parasitology, Surgical Infection Society, European Society of Clinical Microbiology and Infectious Diseases, European Association of Infection Control.

USA:

Texas Society of Infection Prevention and Control, American Society of Microbiology, Canadian Society for Immunology, International AIDS Society, Infectious Diseases Society of America, National Association of Infection Prevention and Control, American Society of Infection Prevention.

Asia Pacific:

Pediatric Infectious Disease Society of Thailand, Infection Control Association, The Japanese Association for Infectious Diseases, Australasian Society for Infectious Diseases, Chinese Society for Immunology, Asia Pacific Society of Infection Control, Korean Association of Infection Disease Prevention, Korea

The global infection control market size is expected to reach USD 359.6 Billion by 2030. The market is expected to register a CAGR of 6.7% from 2022 to 2030. The market is driven by rising concerns with respect to a significant upsurge in hospital-acquired infections globally. This is believed to facilitate greater penetration of infection control products. An influx in the development of new biologics and subsequent demand for sterilized formulations serve as key growth factors for the overall market. Healthcare organizations are focused on implementing strategies for early recognition, reporting, isolation, and surveillance of disease episodes of potential public health concern.

In addition, an increasing number of intensive training modules, for nurses and other medical staff, on infection prevention and control is presumed to provide high potential for extensive usage of infection control products over the coming years. For instance, College of Nurses of Ontario released guidelines concerning a standard practice, which is focused on maintaining hand hygiene to reduce contamination and spread of infection. Furthermore, Centers for Disease Control and Prevention (CDC) has released guidelines for disinfection and sterilization for efficient usage of infection control products by healthcare personnel in a wide array of healthcare settings such as ambulatory care, home care, hospitals, and others.